MarketPulse — Real-Time Financial News & Market Analysis

EMR market grows from $31.51B (2025) to $47.68B (2035) at 4.23% CAGR, driven by AI integration and government mandates despite implementation cost challenges.

American Fusion files 20 Texatron patent applications, with 240 more planned through 2026, totaling approximately 260 applications to protect its aneutronic fusion technology.

Nkarta to present at two major healthcare investor conferences in March 2026, showcasing updates on its engineered NK cell therapy pipeline for autoimmune diseases.

AB Volvo converts 2 million Series A shares to Series B, adjusting capital structure and voting rights effective February 27, 2026.

Daqo New Energy reports 14% revenue growth in Q4 2025. Polysilicon industry seeks Chinese government policy support to combat excess capacity and low prices.

Healthcare REITs show divergent economic resilience: Welltower's $145B scale and 3.0x leverage outperform Medical Properties Trust's riskier 8.5x ratio during downturns.

Rocket Lab stock fell 5% after delaying Neutron rocket's first launch to Q4 2026 due to tank failure, despite beating earnings expectations.

DeFi Technologies appoints Philippe Lucet as General Counsel, promoting him from subsidiary Valour. He assumes expanded legal and governance responsibilities for the parent company.

Equinix and CPP Investments jointly acquire Nordic data center operator atNorth for $4B, with CPP taking 60% stake and Equinix 40%, expanding Scandinavian infrastructure presence.

Juggernaut Exploration raises C$10M through flow-through private placement to fund exploration of its Big One Gold Project in British Columbia's Golden Triangle.

TransAlta posts strong 2025 results with $1.1B EBITDA and raises dividend 8%. Data centre demand accelerates growth through major partnership and strategic acquisitions.

SMR sector offers two paths: Oklo pursues innovation without revenue, while BWX balances profitability with proven operations. Investors choose between high-risk tech or stable growth.

Caris Life Sciences beat earnings expectations with 28-cent EPS and 125% revenue growth. Its cancer detection test showed clinical superiority, driving 20% stock gains.

Range Resources increases quarterly dividend by 11%, raising annualized payout to $0.40 per share, reflecting strong operational performance and financial confidence.

EMA committee endorses mavorixafor (XOLREMDI) for WHIM syndrome treatment, marking first approved therapy in Europe. Final Commission approval expected Q2 2026.

YieldMax launches MINY ETF using options strategies to generate income from strategic metals and mining companies, starting February 27, 2026.

Salesforce reported strong Q4 results with 12% revenue growth and 37% earnings expansion, driven by AI platform Agentforce. The company authorized $50B in buybacks and increased dividends, signaling confidence.

Energy infrastructure companies offer yields up to 14.8% through fee-based models that provide stable cash flows independent of commodity prices, attracting income-focused investors.

IonQ stock surged 19% on strong Q4 results, beating guidance by 55%. Company raised 2026 revenue guidance to $225-245 million, signaling confidence in growth.

Paramount-Skydance's $111B Warner Bros. deal faces scrutiny over leadership concentration and merger risks. Regulators probe competitive concerns as Senate hearing scheduled.